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Modern clearing techniques for the three-dimensional (3D) visualisation of neural tissue
microstructure have been very effective when used on rodent brain but very few studies have
utilised them on human brain material, mainly due to the inherent difﬁculties in processing
post-mortem tissue. Here we develop a tissue clearing solution, OPTIClear, optimised for
fresh and archival human brain tissue, including formalin-ﬁxed parafﬁn-embedded material. In
light of practical challenges with immunostaining in tissue clearing, we adapt the use of cresyl
violet for visualisation of neurons in cleared tissue, with the potential for 3D quantiﬁcation in
regions of interest. Furthermore, we use lipophilic tracers for tracing of neuronal processes in
post-mortem tissue, enabling the study of the morphology of human dendritic spines in 3D.
The development of these different strategies for human tissue clearing has wide applicability
and, we hope, will provide a baseline for further technique development.
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The brain is arguably the most complex organ in the humanbody. For centuries, efforts have been made to try andunderstand the structural and functional connections
within the brain. At the macroscopic level, diffusion tensor
imaging and functional magnetic resonance imaging are begin-
ning to unravel some of the complex connections between dif-
ferent anatomical regions. However, due to the spatial resolution
of these imaging modalities, they lack the ability to reveal details
at the microcircuit or cellular level1.
As the founder of the neuron dogma Santiago Ramόn y Cajal
stated, “the key to understanding turns on the nature of available
instrumentation”2. A recent resurgence of interest in tissue
clearing techniques that can render opaque tissue transparent,
combined with the advances in ﬂuorescent labelling probes and
imaging technologies, has proven useful in the study of neuro-
pathology in three dimensions (3D). For example, CLARITY3,
which renders a piece of acrylamide hydrogel-hybridised tissue
transparent by detergent-based delipidation, has been used to
study Alzheimer’s4, Lewy body5 and neurodevelopmental3,6
pathologies in 3D. Furthermore, ScaleS, a tissue-clearing strategy
using serial immersion of tissue in a sorbitol-based solution,
successfully demonstrated the spatial relationships between
microglia and amyloid-beta plaques in Alzheimer’s disease (AD)
brain tissues7. Despite the great potential of tissue clearing in
human neuropathological research, these techniques were initially
developed for rodent brain research. Although attempts have
been made to simplify and improve efﬁciency of tissue clearing in
human tissues8, there are many unresolved issues that remain to
be addressed. In particular, the limited penetration of antibodies
appears to be a universal problem faced by many groups working
on tissue clearing9. Hence, it is important to explore whether
more traditional histological staining strategies can be used
effectively with modern tissue clearing methods.
It is increasingly apparent that the inherent differences between
rodent and human tissue warrants the development of a tissue-
clearing method dedicated to human brain tissue5. Fundamen-
tally, there are signiﬁcant differences in gross size, physiochemical
properties and neuronal and myelin densities between rodent and
primate brains10, making clearing more challenging in human
tissues. Furthermore, although the study of neuronal connectivity
can be aided by ﬂuorescent labelling technologies using genetic or
viral tracers11, such techniques are not available for human post-
mortem studies. From a practical point of view, working with
human tissue is further complicated by uncontrollable variables
including the pre-mortem agonal state of the patient and the
post-mortem delay.
On the basis of our understanding of the mechanisms of tissue
clearing and the properties of human neural tissues, we have
deconstructed some of the current techniques and identiﬁed three
major aims for this study: (1) to develop a refractive index
homogenisation solution optimised for human tissue clearing
research; (2) to optimise tissue clearing for prolonged formalin-
ﬁxed and parafﬁn-embedded materials, thereby freeing up
archival tissues for research; and (3) to explore the compatibility
of traditional non-immunohistochemical histology staining
methods with tissue clearing.
Due to the inherent variability of human tissue, no single
protocol is appropriate in all situations. Our objective here was to
develop a series of strategies for human brain tissue clearing
which are simple to execute and can be used as the basis for
further 3D histological studies. Here we present the development
of a refractive index homogenisation reagent, OPTIClear (for
Optical Properties-adjusting Tissue-Clearing agent), which is
optimised for tissue clearing in both fresh and archival human
brain tissues, including formalin-ﬁxed parafﬁn-embedded (FFPE)
materials. This has enabled us to establish various protocols for
3D histological investigations for the study of the human brain in
health and disease.
Results
Development of OPTIClear. Refractive index homogenisation is
a crucial step in tissue clearing. It was previously suggested by
Richardson and Lichtman12 that the role of refractive index-
matching solutions is to reduce inhomogeneity within tissues to
minimise scattering of light. We further hypothesised that tissue
opacity originates mostly from the refractive index mismatches
between different compartments in the tissue, which is most
signiﬁcant between hydrophobic (e.g., lipid membranes and lipid
droplets) and hydrophilic (e.g., extracellular space, cytosol and
nucleus) compartments. Therefore, we reasoned that the appli-
cation of compartment-selective refractive index-adjusting agents
would allow matching of these compartments’ refractive indices
(Supplementary Figure 1a). We performed screening experiments
using a modiﬁed version of strategies by Susaki et al13 (Supple-
mentary information), which led us to identify iohexol and 2,2’-
thiodiethanol as appropriate refractive index-adjusting agents for
hydrophilic and hydrophobic compartments, respectively (Sup-
plementary Figure 1b). Furthermore, chemicals such as urea7,14
and formamide15 are used in many tissue-clearing agents. These
are necessary for tissue clearing agents to inﬁltrate effectively and
homogenously into the dense proteinaceous cytosol due to partial
denaturation of proteins (Supplementary Figure 2) in non-
delipidated tissues. However, these chemicals are strong dena-
turants and may destroy the tissue. To search for mild dena-
turants, we screened for chemicals that can solubilise boiled egg
whites, and identiﬁed N-methylglucamine to replace urea in our
formula. (Supplementary Information, Supplementary Figure 2).
Subsequent optimisation with brain homogenates established the
optimal concentrations of these three principal components (20%
w/v N-methylglucamine, 25% w/v 2,2’-Thiodiethanol, 32% w/v
Iohexol), and the resulting cocktail is termed OPTIClear. It is a
clear colourless liquid with a refractive index of 1.47–1.48.
To test its efﬁcacy of tissue clearing on human tissues, a 1 mm-
thick piece of formalin-ﬁxed human brain tissue was incubated in
OPTIClear for 6 h and it was rendered transparent even without
prior delipidation in SDS. The degree of tissue transparency and
decolorisation was improved with prior SDS delipidation (Fig. 1a,
upper panel).
The fact that OPTIClear alone is sufﬁcient to render a small
non-delipidated piece of human brain tissue transparent supports
its working principle based on compartment-selective refractive
index modulation. Furthermore, thick blocks (>5 mm) of human
brain tissue, which remained opaque after 3.5 months of
delipidation, were rendered transparent after further incubation
in OPTIClear for 6 h (Fig. 1a, lower panel). Despite OPTIClear’s
high tissue-clearing efﬁcacy, it only causes minimal structural
disturbance to the tissue down to the ultrastructural level
(Supplementary Figure 3).
OPTIClear is compatible with most ﬂuorescent dyes; however,
it decreases ﬂuorescence for ﬂuorescein, AlexaFluor488, Dylight
dyes and rhodamine, requiring higher laser power for imaging
compared to in PBST buffer (Supplementary Figures 4 and 5,
Supplementary Table 4). We dissected the components of
OPTIClear and found iohexol to be responsible for the poor
ﬂuorescence signal with xanthene dyes (Supplementary Figure 6).
As expected, other tissue-clearing agents containing iodinated
radiocontrasts also have a reduction in ﬂuorescence signal.
Interestingly, the lower the concentration of iohexol, the better
the ﬂuorescence signal is preserved, as demonstrated here with
OPTIClear (Supplementary Figure 6b). In addition, to see
whether such decrease in ﬂuorescence would lead to increased
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bleaching, we found it reassuring that OPTIClear (along with
some other tissue-clearing agents) did not cause increased
bleaching of ﬂuorescein and AlexaFluor568 (Supplementary
Figure 6c).
Compatibility of OPTIClear with immunoﬂuorescent staining.
We have tested the compatibility of OPTIClear in human brain
immunohistochemistry using a variety of different antibodies,
including GFAP (glial ﬁbrillary acidic protein), NF (neuroﬁla-
ment), TH (tyrosine hydroxylase), Iba-1, ZO-1 (zonula occlu-
dens-1), HLA DQ/DR/DP (CR3/43), alpha-synuclein (αSN), tau,
synapsin 1, calretinin and choline acetyltransferase (ChAT)
(Supplementary Figure 7). In this study, we were not able to
successfully stain for ChAT, αSN and calretinin, with or without
SDS delipidation for 5 days. It is interesting to note that Iba-1
staining was not possible after 5 days of treatment with SDS.
We have also compared the clearing capability and ﬂuores-
cence signal retention between OPTIClear and four other existing
clearing solutions including CUBICScale, PROTOS, ScaleS and
RIMS (Supplementary Figure 8). The performance of OPTIClear
was similar to other solutions tested, but the tissue clearing
performance was best with CUBICScale-clearing and PROTOS-
clearing solutions. However, when tissues were re-imaged after
3 days of incubation in the clearing solution, OPTIClear had the
best signal preservation compared with other solutions. We
further show that ﬁne structures such as dendritic spines, as well
as endogenous ﬂuorescence (YFP), immunoﬂuorescence with
AlexaFluor488 and lectin with Dylight488 were preserved in
OPTIClear for >500 days at room temperature (Supplementary
Figure 9); however, the signal intensity of ﬂuorescent staining
decreased and thus we recommend storage of stained tissue in
PBS rather than OPTIClear.
Tissue clearing for archival materials. Using OPTIClear and a
prolonged delipidation treatment with SDS (>3 months), we
performed 3D immunohistochemistry on archival tissues that
have been extensively formalin-ﬁxed for up to 50 years. We were
able to achieve 300 µm deep immunostaining with good struc-
tural preservation on a piece of 2 mm-thick cingulate cortex from
the Corsellis collection (with formalin ﬁxation over 30 years).
Using antibodies against GFAP, ﬁne processes of the astrocytes
forming the blood–brain barrier were well-visualised under high
magniﬁcation in 3D (Fig. 1b, Supplementary Figure 10a).
We have also explored the use of FFPE tissue in tissue clearing
(Supplementary Figures 10b, c). Tissue was ﬁrst dewaxed with
heat and xylene before rehydration in decreasing gradients of
tetrahydrofuran. Staining with anti-GFAP showed ﬁne astrocytic
processes can be visualised clearly and individually traced
(Fig. 1c), indicating excellent preservation of tissue structures
following retrieval of FFPE tissues.
Non-immunohistochemical staining methods for tissue clear-
ing. We screened through various traditional dyes used in routine
histology and identiﬁed cresyl violet acetate as a useful pan-
neuronal marker as it emits red ﬂuorescence upon excitation with
the Argon laser (488 nm). Further optimisation of the staining
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Fig. 1 Immunoﬂuorescence staining of archival brain tissues. a Upper panel:
comparison of formalin-ﬁxed human cerebellar tissue immersed in PBS
(left), OPTIClear (middle) and OPTIClear after 5 days of SDS delipidation at
55 °C (right). Lower panel: comparison of 5 mm-thick, formalin-ﬁxed
human striatum tissue block after 3.5 months of SDS delipidation at 55 °C,
before (left) and (after) OPTIClearing. b Colour depth-coded, Z-stack
image of a block of 2 mm-thick cingulate cortex that has been formalin-
ﬁxed for 50 years, stained with antibodies against GFAP with an imaging
depth of 125.57 µm. The tissue was cleared after SDS treatment for
4 months at 55 °C and cleared in OPTIClear. Scale bar= 50 µm. c Z-stack
image of a piece of formalin-ﬁxed, parafﬁn-embedded midbrain tissue
immunostained for GFAP (red) and counterstained with DAPI (blue) after
dewaxing and rehydration (Z-stack depth= 20.77 µm)
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protocol, inspired by system-wide binding kinetics control and
staining regression in traditional histology, achieved a desirable
staining contrast and quality (Supplementary Methods, Supple-
mentary Figure 11). Formalin-ﬁxed tissue can be readily stained
with cresyl violet and be rendered transparent using OPTIClear
without the need for SDS delipidation. Using such a method, a
piece of formalin-ﬁxed tissue can be stained and visualised within
~5 h. Cresyl violet staining is also applicable to prolonged
formalin-ﬁxed or FFPE tissues after SDS treatment. The dis-
tribution of cresyl violet staining gives a speciﬁc subcellular
staining pattern resembling that normally seen for Nissl sub-
stance, namely a perinuclear distribution with extension in the
dendrites. The use of cresyl violet in tissue clearing is most useful
for visualising magnocellular neurons. For example, in the
inferior olivary nucleus, where a speciﬁc molecular marker for the
magnocellular neurons is lacking, cresyl violet staining can
effectively demonstrate their distribution in 3D space (Fig. 2a).
Fluorescently conjugated Lycopersicon esculentum lectin was
another non-immunohistochemical marker compatible with
OPTIClear. It stains blood vessels within brain tissue and could
be used as a useful counterstain with immunoﬂuorescence. In this
study, a piece of tissue ﬁxed in formalin for 45 years
immunostained for zona occludens-1 (ZO-1), was counterstained
with DyLight 649-labelled lectin, demonstrating the intricate
blood vessel network in the brain (Fig. 2b).
3D neuronal tracing using lipophilic tracer. Since OPTIClear is
detergent-free and denaturant-free, it is compatible with lipo-
philic tracers, enabling 3D visualisation of neuronal projections in
rodent and human brain tissue. The tracings remained stable
even after storing in OPTIClear for 2–3 weeks (Supplementary
Figures 12, 13). In this study, DiI crystals were embedded in the
deep white matter of a piece of cerebellar tissue for 10 days
achieving a diffusion distance of 3–4 mm (Fig. 2c). Tissue was
subsequently immersed in OPTIClear solution for 6 h and spar-
sely labelled mossy ﬁbres in a single folium were visualised under
confocal microscopy (Fig. 2d). A large number of dendritic spine-
like projections in the human brain were visualised in 3D (Fig. 2e)
for which computer surface rendering can be performed (Sup-
plementary Movie 1).
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Fig. 2 Non-immunohistochemical staining with tissue clearing on formalin-ﬁxed brain tissues. a Colour depth-coded image with maximum intensity
projection of a piece of 1-mm-thick medulla block stained with cresyl violet and cleared with OPTIClear (z-stack depth= 228.83 µm). Lower image showing
a zoomed and tilted view of area outlined by the white box. b A piece of frontal cortical block immunostained for ZO-1 (green) and counterstained with
DyLight 649-labelled Lycopersicon esculentum lectin (red). c DiI crystals were inserted into a cerebellar folium to trace the ﬁbres up to the granular layer,
followed by tissue clearing with OPTIClear for 6 h at 37 °C. Most of the ﬁbres traced were mossy ﬁbres. The inset shows the gross appearance of the
sample with red crystals of DiI inserted within the OPTICleared sample. d Enlarged view of the white boxed region in a. with colour depth-coding (Z-depth
151.09 μm). e Z-stack images of dendritic spine-like projections visualised in areas outlined by white boxes. Scale bars, 1 μm
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3D neuroanatomy of the human spinal cord and cerebellum. A
2 mm-thick lumbar spinal cord section was incubated in SDS for
7 days and immunostained with antibodies for neuroﬁlament to
visualise its cytoarchitectural elements. With a total processing
time of 10 days, we were able to clearly demonstrate the 10
laminae of Rexed based on their distinctive cytoarchitectural
characteristics, as well as tracing inputs and outputs into each
lamina (Fig. 3a). Prolonged tissue delipidation produced better
tissue transparency. As an example, a 1500 µm-thick piece of
cerebellar tissue was SDS treated for 3.5 months, immunostained
for neuroﬁlament, and incubated in OPTIClear solution for 3 h.
Numerous thick immunopositive neuronal processes, which are
occasionally continuous with some immunopositive soma, were
visualised in detail (Fig. 3b).
Detailed mapping of the brainstem catecholaminergic system.
3D immunohistochemical staining using anti-tyrosine hydro-
xylase (TH) antibody was used for the mapping of
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catecholaminergic cell groups in the human midbrain block. In a
2 mm-thick hemi-midbrain slice from a healthy donor with SDS
delipidation of 3.5 months, our antibody staining achieved
around 250 μm penetration from both surfaces, which enabled
the visualisation of many cell groups at once as well as con-
tinuous, traceable TH-positive ﬁbres. Using this method, cellular
morphology and ﬁbre projections were clearly visualised. We
were able to stain for TH-positive neurons located within the
substantia nigra pars compacta and its associated paranigral
nucleus, ventral tegmental area, parabrachial pigmented nucleus,
mesencephalic reticular formation, caudal/rostral linear nucleus
and dorsal raphe nucleus, with their detailed morphologies
including third-order axonal branches visualised all at once
(Fig. 4, Supplementary Figure 14).
Visualisation and quantiﬁcation of basal forebrain neurons.
We performed 3D histological staining using cresyl violet on a
2.5 mm-thick piece of basal forebrain tissue containing the
nucleus basalis of Meynert (nbM) in a healthy control. With a
total processing time of 5 days (3 days of SDS delipidation, 1 day
of staining and 1 day of incubation in OPTIClear), we were able
to image down to a total depth of 1000 µm (500 µm on each side).
The staining highlighted regions densely populated by neurons,
leaving white matter or myelin-rich regions dark. Using this
technique, we were able to visualise how magnocellular neurons
of the nbM were arranged spatially in relation to other anatomical
structures (Fig. 5a). With automated annotation, individual
neurons were assigned a spatial coordinate and the inter-cellular
distance calculated (Fig. 5b, Supplementary Figure 15).
Discussion
Despite the multitude of brain tissue-clearing techniques cur-
rently available, none were originally developed or optimised on
human pathological samples. Compared to rodent brain tissue,
human tissue has a considerably longer processing time5,16.
Moreover, due to the prolonged formalin ﬁxation in most
archival materials, the quality of immunostaining is often poor
due to antigen masking by excessive formaldehyde protein
crosslinks17. Previously, we developed a more efﬁcient tissue-
clearing protocol which improved immunostaining in human
brain samples, and it greatly reduced the complexity and speed of
the delipidation-based clearing techniques by eliminating the
acrylamide-embedding step8. In this study, we have further
optimised the technique and developed a selection of different
strategies for human tissue-clearing research (Fig. 6, Supple-
mentary Movie 1). On the basis of the concept of compartment-
selective refractive index adjustment, a refractive index homo-
genising agent, OPTIClear, has been developed. This solution is a
detergent-free and denaturant-free formula that is thought to
alter only optical properties of the tissue with minimal structural
and molecular disturbances. This has enabled an efﬁcient
tissue-clearing protocol and it is compatible with different
molecular labelling methods. These include its compatibility with
lipophilic tracing, and rapid visualisation of cytoarchitecture
using non-immunohistochemical staining methods such as cresyl
violet and lectin staining. Interestingly, iodinated radiocontrasts
would decrease the ﬂuorescence of many xanthene dyes. Since
iodinated radiocontrasts are the principal components of many
tissue-clearing formulae, the search for alternatives or formulae
with lower concentrations of iodinated radiocontrasts may lead to
further development in tissue clearing.
Immunostaining with tissue clearing using human tissues
remains challenging. Although we demonstrated good staining
with antibodies against a variety of antigens, staining remained
difﬁcult for some (including calretinin and ChAT). Also, antigens
such as Iba-1 may be masked following treatment with SDS. This
prompted further work in the optimisation of immunostaining in
human brain tissues for tissue clearing. We discovered that,
although the clearing performance of OPTIClear, CUBICScale
and PROTOS were similar, OPTIClear had a better preservation
of ﬂuorescent signal.
Using the optimised protocol, we can now perform tissue
clearing on prolonged formalin-ﬁxed and parafﬁn-embedded
tissues. One practical use is that tissues can then be processed for
3D analysis after routine diagnostic workup (with standard his-
tological and immunohistochemical staining on tissue sections) is
performed. This provides a huge potential for accessing and using
diagnostic archives for research purposes, particularly for rare
neurological disorders. It is important to note, however, that
although staining was possible, the immunostaining quality,
antibody penetration depth and structural preservation were not
as good as standard formalin-ﬁxed tissues when treated with the
same tissue-clearing and immunostaining procedures.
Unlike in rodents (where the maximal size of tissue is the
whole brain), human brain tissue from different regions can vary
in size and tissue composition such that the optical properties and
ease of SDS delipidation may vary. Although duration of formalin
ﬁxation can be standardised, pre-mortem agonal state of the
patients, post-mortem changes such as pH variation and oxyge-
nation of tissue and pathology within the brain (e.g., sclerosis or
necrosis) will mean tissue quality varies considerably from one
brain to another. As a result, we investigated clearing thickness
and imaging depth of incubation with OPTIClear solution with
varying duration of SDS treatment. First, we were able to achieve
a clearing thickness of 1 mm for samples ﬁxed for 1 week (Fig. 1a,
upper panel) without delipidation. Second, an imaging depth of
150 µm was achieved with lipophilic tracer (limited by working
distance, Fig. 2d) for samples ﬁxed for 1 week without delipida-
tion. Third, an imaging depth of 500 µm was achieved with 3 days
Fig. 3 Application of 3D immunohistochemistry with next-generation histology. a Maximum intensity projection image of a 9.5 mm-wide, 8.1 mm-tall, 2
mm-thick spinal cord block stained for neuroﬁlament (imaging Z-depth= 462.60 µm). Magniﬁed view of different laminae was shown in lower images
(Scale bars= 200 µm). Roman numerals from I to X: laminae of Rexed, where the sufﬁx m and l denotes the medial and lateral divisions, respectively. Aβ,
Aδ to III/IV Aβ-type and Aδ-type input ﬁbres from dorsolateral tract to lamina III/IV, Aβ, C to III/IV Aβ-type and C-type input ﬁbres from dorsolateral tract
to lamina III and IV of Rexed, df dorsal funiculus, d. root dorsal root, i.c. VIII interconnecting ﬁbres between bilateral laminae VIII of Rexed, IX to v. root:
output motor ﬁbres from lamina IX of Rexed to ventral root, lcst lateral corticospinal tract, lf lateral funiculus, lf to VII lateral funiculus ﬁbres input into the
lamina VII of Rexed, pst/umt to V propriospinal tracts or upper modulating tracts input into the lamina V of Rexed, v. root ventral root, ?V to lst ﬁbres from
the lamina V of Rexed on the right side coursing through the grey matter to form the lateral spinothalamic tract of the left sid, V to df output tracts from
lamina V of Rexed into the dorsal funiculus, vf ventral funiculus, vf/vmf to VII input ﬁbres from the ventral funiculus or ventromedial funiculus into the
lamina VII of Rexed, vgc ventral grey commissure, vmf ventral median ﬁssureb. A block of 17.6 mm-wide, 9.5 mm-tall, 1.5 mm-thick formalin-ﬁxed
cerebellar folium delipidated with SDS for 3.5 months, immunostained for neuroﬁlament, and cleared with OPTIClear. The inset shows the gross
appearance of the folium. Overview of immunostaining (right) and detailed view demonstrated by colour depth-coded image (below; Z-depth= 546.00
µm) from the white boxed area on the right.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03359-w
6 NATURE COMMUNICATIONS |  (2018) 9:1066 | DOI: 10.1038/s41467-018-03359-w |www.nature.com/naturecommunications
of delipidation with cresyl violet staining for samples ﬁxed for
3 weeks (Fig. 5). Finally, an imaging depth of 1500 µm was
achieved with 3.5 months of delipidation for samples ﬁxed for
1 week with immunoﬂuorescence (Fig. 4). In a recent study using
a modiﬁed CLARITY protocol (hydrogel embedding with 2%
acrylamide/0.05% bisacrylamide), human brain samples were
cleared and imaged down to 5 mm in depth with both active
(electrophoretic) and passive SDS clearing for ~10–14 months.
The tissue remained structurally intact even after prolonged SDS
clearing. Similar to our present study, tissue block was optically
opaque and only became visibly transparent after refractive index
homogenisation with 47% TDE18. These studies demonstrated
ﬂexibility in the timing of SDS clearing, while maintaining
structural integrity for morphometric analyses (Figs. 4 and 5)
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regardless of the ﬁxation duration, SDS treatment duration and
the brain region sampled. Hence, this exempliﬁes an important
concept in the development of next-generation histology, that
refractive index homogenisation (in this case with OPTIClear) is
the most important step in optical clearing. While SDS treatment
(used in CLARITY) can be used as an adjunct, it is not a
necessary step for tissue clearing with OPTIClear, instead we
hypothesise that it has a crucial role to ensure adequate tissue
permeabilization and antigen retrieval for immunohistochemical
staining. Furthermore, on a practical note, we observed that the
depth of antibody penetration depended more on the density of
the antigens and the amount of antibody added, rather than on
the incubation time. Further investigations on the factors gov-
erning antibody penetration depth and staining quality are thus
necessary. In general, given sufﬁcient amount of antibody, we
observed that a permeabilisation step with PBST would allow
antibody penetration of at least 200 μm.
In routine pathology practice, the use of structural stains such
as haematoxylin and eosin (H&E) or Luxol fast blue with cresyl
violet (LFB/CV) is important for tissue orientation by identiﬁ-
cation of key anatomical landmarks. However, so far only
immunoﬂuorescence staining has been performed on cleared
human brain tissues4,5. We have developed a protocol for the use
of cresyl violet staining on tissue blocks which can subsequently
be cleared using OPTIClear. This stained neuronal somata and
enabled the visualisation and quantiﬁcation of neurons in the 3D
space. Similar to histological staining on tissue sections, cresyl
violet staining with tissue clearing is simple and rapid—a small
piece of formalin-ﬁxed tissue block could be stained and readily
visualised within 5–6 h using this method. In this study, we used
cresyl violet staining on a block of basal forebrain tissue to
visualise the distribution of cholinergic magnocellular neurons in
the nbM. Normally, cholinergic neurons are identiﬁed using
antibodies against ChAT, an enzyme required for acetylcholine
synthesis19. However, immunostaining with anti-ChAT anti-
bodies has proven challenging on human brain tissues and
staining intensity is greatly affected by pre-mortem and post-
mortem variables20. Since over 90–95% of magnocellular neurons
within the nbM are ChAT immunopositive21, the use of Nissl
staining with cresyl violet for the identiﬁcation of the basal
forebrain cholinergic population is justiﬁed. We have demon-
strated that a 1 mm block of human basal forebrain tissue, con-
taining the nbM, can be delipidated, stained and visualised within
5 days. This method of staining is particularly useful on labelling
magnocellular neurons, which are also found in brainstem nuclei
such as the inferior olivary nucleus. When combined with colour
depth-coding, stained neurons could be individually identiﬁed
and full quantiﬁcation of an area of interest could be performed.
The application of this technique could potentially replace the
current practice of stereology for the quantiﬁcation of neurons in
a discrete nucleus or region of interest.
For immunoﬂuorescence in tissue clearing, one tends to use
nuclear stain, e.g., DAPI, as a counterstain for spatial orientation
under the confocal microscopes3,5. Here apart from cresyl violet
staining, we demonstrated staining with ﬂuorescent-labelled lec-
tin can be used as a counterstain in immunoﬂuorescence studies
to visualise blood vessels in brain tissue blocks. This acts as a
structural landmark which is another method to aid orientation
of tissue in the 3D space. It is also suitable in studies involving the
blood–brain barrier, such as the investigation of endothelial tight
junction as demonstrated in the present study using immuno-
ﬂuorescence staining to ZO-1.
Transgenic animals with ﬂuorescent protein-labelled neurons,
e.g., Thy1-YFP mice, can be used to trace axonal and dendritic
processes of an individual neuron in its entirety22. When com-
bined with tissue-clearing technology, this can be very powerful
in the study of anatomical and structural connections of the
brain3. However, in humans, neuronal tracing can only be per-
formed post-mortem and this has been demonstrated using Golgi
stain or the carbocyanine dye, DiI23. Since DiI is a lipophilic
tracer, it is not compatible with existing tissue clearing techniques
which involve the use of organic solvent or delipidation. With the
use of OPTIClear, the lipid membranes are well-preserved, such
that neuronal processes of a block of cerebellar tissue could be
successfully traced with DiI. For the ﬁrst time, human dendritic
spine-like projections could be visualised in 3D and the mor-
phology is comparable to previous studies on human hippo-
campal sections23,24, a goal that has not been achieved by other
tissue-clearing techniques or traditional histology.
Use of the reﬁned tissue clearing technique and 3D histology
can complement existing human anatomical atlases. Neuropil and
neuronal soma have long been used for the deﬁnition of neu-
roanatomical areas or regions since the time of Ramόn y Cajal25.
Using immunostaining for neuroﬁlament with tissue clearing on
a thick tissue block, a detailed perspective on the cytoarchitectural
elements that deﬁne various anatomical regions can be visualised.
Since the size of the neuroﬁlament in immunohistochemistry
correlates with the actual axo-dendritic diameter, it provides a
convenient approach to the estimation of type of neuronal
ﬁbres26. Hence, we were able to create a fully annotated cross-
section of a piece of human spinal cord in this study with the 10
laminae of Rexed clearly identiﬁed. In the human caudal mid-
brain, we have demonstrated that complete mapping of a neu-
rotransmitter system is possible. TH-positive cells and their
projections can be labelled and traced over great distances.
Normally, the demonstration of cellular morphology and tracing
of ﬁbre projections is often not possible with conventional his-
tology due to the substantial tissue deformation that leads to
difﬁculties in registering individual ﬁbres across sections. Also,
array tomography with in silico reconstruction is unsuitable for
such studies due to the limits in sectioning surface area for epoxy
resin-embedded samples27. In this study, immunostaining of TH
Fig. 4 3D mapping of the brainstem catecholaminergic system. a. A maximum projection image of a 21.6 mm-wide, 12.2 mm-tall, 1.5 mm-thick slice of
midbrain immunostained for tyrosine hydroxylase (TH) with an imaging depth of 1748.36 µm. Zoomed images showing detailed morphology of TH-
immunopositive neurons. Highlighted areas are presented with analyses in subsequent subpanels. b–d Reticular formation pictured in a, b maximum
projection image with 10 neurons traced and segmented, which are presented in c, based on which Sholl analysis has been performed and the results for
neuron [1] shown in d. The results for other neurons is presented in Supplementary Figure 14. The cartesian coordinates (in µm) were labelled for the
longest path length with the soma marked as the origin. The number of intersections was colour-coded. Nav is the average number of intersections of the
entire arborisation, and is computed by dividing the area under the ﬁtted polynomial function by the maximal radial extent of the neuronal ﬁbres. The
critical radius is radial distance from soma where the maximum number of intersections occurs. e The medial border of the sample in the anatomical
location of caudal linear nucleus, where the antibody penetration was adequate for image throughout the thickness of the sample. This is exempliﬁed by a
ﬁbre (highlighted by arrowheads) travelling caudocranially along the Z-direction. Z-depth colour-coded 3D rendering, scale bar on the left upper corner is
500 µm. f A Z-depth colour-coded 3D rendering of the substantia nigra reticulata demonstrating curliform TH-positive ﬁbres as they are being separated
by the descending tracts from the cortex. Some of these has been traced demonstrating ﬁbre lengths and neuronal span up to 3457 µm and 2682 µm,
respectively
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Fig. 5 3D visualisation and quantiﬁcation of basal forebrain magnocellular neurons. a Three-dimensional cresyl violet staining for the visualisation of the
nucleus basalis of Meynert (nbM) on a 10.8 mm-wide, 5.5 mm-tall, 2.5 mm-thick basal forebrain block (imaging Z-depth= 1120.00 µm). Tissue block was
delipidated with SDS for 3 days and stained with cresyl violet for 3 days (gross appearance shown in inset). Image on bottom left showed magniﬁed view of
selected areas from top image. Z-positions of the quantiﬁed and annotated neurons were colour-coded according to the reference bars, where the
numerical values indicate the distances from the imaging objective for each end of the spectrum (bottom right). b–d Quantiﬁcation of magnocellular
neurons in region of interests highlighted in b (white boxes), where the coordinates of each neuron were marked and annotated (c). d 4D scatter plot of all
3528 neurons, the distance of each neuron to its nearest neighbour was calculated and represented with colour coding. More detailed statistics were
provided in Supplementary Figure 15. ac anterior commissure, fx fornix, inf infundibulum, nbM nucleus basalis of Meynert
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Fig. 6 Flowchart summarising the next-generation histology protocol developed in this paper. The protocol outlined here enables both fresh and archival
formalin-ﬁxed parafﬁn-embedded (FFPE) post-mortem tissues to be processed for tissue clearing. Formalin-ﬁxed tissues can then be stained using
immunohistochemical or non-immunohistochemical techniques such as lipophilic dye tracing with DiI or 3D chemical staining with cresyl violet. An
optional SDS delipidation step is recommended before 3D immunostaining or chemical staining. Subsequently, tissues are rendered optically transparent
with refractive index homogenization using OPTIClear before imaging or proceeding to other studies such as electron microscopy. H&E, haematoxylin &
eosin; RI, refractive index; SDS, sodium dodecyl sulphate; TEM, transmission electron microscopy
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in the human midbrain block was comparable to a previously
published atlas of catecholaminergic neurons in human28. How-
ever, the somal branching pattern appeared more extensive
(Fig. 4) and ﬁne TH-positive ﬁbres, over a Z-depth of 1500 μm, or
up to 3000 μm in length, can be readily traced. (Fig. 4, Supple-
mentary Figure 14). These groups of ﬁbres could have been
missed in earlier studies, as the TH-positive ﬁbres were char-
acteristically sparse, particularly in thin histological sections. This
demonstrates the advantage of the current technique over stan-
dard histological studies and highlights the importance of revi-
siting older structural anatomical studies.
Despite potential applications of tissue clearing in human tis-
sues identiﬁed in the current study, there are still several issues
that remain to be resolved. Autoﬂuorescence in human tissues
and prolonged ﬁxation of post-mortem material are difﬁcult
issues to tackle, and so far the use of conventional reagents that
reduces autoﬂuorescence in tissue sections have failed to work as
effectively in thick tissues29,30. Although prolonged incubation in
SDS helps, speeding up tissue decolorisation can enhance ﬂex-
ibility of the process. Effective immunohistochemistry in cleared
thick tissue blocks remains a challenge9, particularly in human
brain tissues which have been extensively ﬁxed. Antibody pene-
tration depth can be inconsistent and although several methods
have been proposed to overcome this issue in animals, including
the use of electric ﬁelds31 and system-wide binding kinetics
controlling agents29, we have found that they are either inap-
plicable to human tissues, incompatible with double immuno-
ﬂuorescence and indirect immunohistochemistry, or that they
lead to signiﬁcant non-speciﬁc staining. Regardless of which
approach is taken, the large amount of antibodies needed for large
scale neuropathological studies can be a limitation and therefore
the development of alternatives such as chemical probes and
aptamers needs further attention. Finally, the immunostaining
quality of the same antibodies in conventional slices and delipi-
dated tissues can occasionally differ signiﬁcantly, thus immu-
nostaining and antigen retrieval conditions need optimisation for
each antibody individually.
In summary, we have developed a selection of protocols for the
study of human brain tissue in 3D, which are ﬂexible and versatile
for use by histopathologists to address different research ques-
tions concerning microstructural anatomy in health and disease.
These strategies are simple to execute and will hopefully provide
the basis for further technique development.
Methods
Next-generation histology pipeline. The next-generation histology pipeline
consists of appropriate tissue retrieval and preservation methods, an aqueous-based
tissue-clearing method with optional tissue delipidation, 3D immunoﬂuorescence,
3D histochemical staining, lipophilic dye tracing and imaging, after which the
sample can be restored by washing in PBST at 37 °C for another round of next-
generation histology processing. A detailed, step-by-step protocol has been
uploaded to Protocol Exchange. Example tissue processing schemes have been
provided in Supplementary Table 3 for the ﬁgures presented in this study.
Collection and preparation of human brain tissue. The tissue used in this study
was provided by the Parkinson’s UK Tissue Bank at Imperial College London and
by the Corsellis archival collection. Fresh brain tissue blocks of approximately 1
cm3 in size were collected from the Parkinson’s UK tissue bank and were ﬁxed in
10% buffered formalin for one week before proceeding. Blocks of routine diagnostic
tissue, taken from whole or hemisected brains ﬁxed in formalin for 3–4 weeks, were
also used. Wet tissue taken from Corsellis collection cases had been ﬁxed in for-
malin for at least 30 years.
Archival FFPE brain tissue was also used in this study. Excess parafﬁn wax was
carefully trimmed away using a scalpel followed by incubation in a 60 °C oven until
all the wax was molten. The tissue was then incubated in xylene at 60 °C overnight
and rehydrated through a graded series of tetrahydrofuran solutions (100, 80, 50,
20%) for 1 h each at room temperature. The retrieved tissue was then treated in the
same way as standard formalin-ﬁxed tissue for processing as detailed below.
Immunoﬂuorescence staining. Immunostaining of processed tissue blocks fol-
lowed our previously published FASTClear protocol8. First, formalin-ﬁxed tissues
were dissected into smaller blocks (~5 mm in thickness) and were immersed in 4%
SDS (dissolved in 0.2 M sodium borate, pH 8.5) at 55 °C for delipidation. The
duration of SDS treatment varied and was dependent on the extent of tissue
discolouration, the desired transparency, the size of the tissue block and the
antigens to be detected. As a rule of thumb, (i) the longer the tissue ﬁxed in
formalin, the longer the SDS treatment recommended; (ii) White matter regions
require longer SDS treatment (at least 10 days is recommended) than grey matter;
(iii) for the speciﬁc antibody used, the harsher the antigen retrieval condition
required in standard immunohistochemistry on tissue sections, the longer the SDS
treatment recommended for intact tissue blocks; and (iv) the longer the SDS
treatment, the less brownish discoloration, autoﬂuorescence and non-speciﬁc
binding of antibodies to lipofuscin. For example, for the immunostaining of neu-
roﬁlament on routine diagnostic tissues, 5–7 days of SDS delipidation is normally
sufﬁcient. For prolonged formalin-ﬁxed materials, a delipidation time of
~3 months may be required. Note that after SDS delipidation, complete trans-
parency of the tissue block is not required.
Next, the tissue was washed in phosphate-buffered saline (PBS) with Triton X-
100 (PBST; 0.1% Triton X-100 (vol/vol) and 0.01% sodium azide (wt/vol)) at 37 °C
overnight. The tissue was then immunostained with primary antibody in PBST at
37 °C for at least 2 days, with daily supplementation at a dilution of 1:100. The
amount of antibody used, as well as the primary antibody incubation period can be
extended if necessary. 1% bovine serum albumin or 6% normal donkey serum can
also be added if deemed necessary to reduce non-speciﬁc staining. For most
antibodies, a starting concentration of 1:100 could be used. For densely expressed
antigens (e.g., glial ﬁbrillary acidic protein, GFAP), we recommend a starting
concentration of 1:500 with daily supplementation at 1:100 for 1 week. All
antibodies used in this study are listed in Table 1 below.
The tissue was then washed in PBST at 37 °C three times over the next 24 h and
incubated with secondary antibody in the same procedure as per primary antibody
incubation described above. Due to the yellow–brownish discoloration of human
brain tissues, ﬂuorophores with absorbance emission spectra as bathochromatically
shifted (near-infrared spectrum) as possible are recommended (e.g., Alexa Fluor
647-conjugated antibodies). A nuclear counterstain (e.g., 4’,6-diamidino-2-
phenylindole, DAPI at 1 μg/ml) or ﬂuorophore-conjugated lectin stain (1:100;
DyLight 649-labelled Lycopersicon esculentum lectin; Catalog Number: DL-1178;
Vector Labs, UK) for blood vessels can also be added in this step. After
immunostaining, the sample was washed in PBST at 37 °C three times over the next
24 h before proceeding to refractive index homogenisation and imaging.
Non-immunohistochemical staining with cresyl violet. Cresyl violet staining was
performed with either delipidated or untreated formalin-ﬁxed tissue. The tissue
was incubated in 0.1% cresyl violet acetate with 3.6% SDS in borate buffer at 37 °C
for at least 2 h, followed by immersion of the tissue in 0.25% acetic acid in 100%
methanol at room temperature until grey–white matter differential staining was no
longer present (Supplementary Figure 16). This procedure should take no longer
than 30 min as it may cause precipitation of tissue proteins and subsequent difﬁ-
culties in immunohistochemistry.
Lipophilic tracer labelling with DiI. Lipophilic tracing was performed by inserting
crystals of 1,1’-Dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate (DiI)
(Catalogue number: D282; ThermoFisher Scientiﬁc, UK) into the white matter of a
piece of formalin-ﬁxed brain tissue (without prior SDS delipidation). A small
incision was made in the tissue to facilitate insertion of the crystals. Afterwards the
tissue was immersed in PBS to keep the tissue hydrated, taking care to not dislodge
the crystals and incubated at 37 °C before proceeding to refractive index homo-
genisation. The duration of incubation depends on the speciﬁc nature of the study.
In the current study, a 3–4 mm diffusion distance was achieved with 10 days of DiI
embedding in a 5-year-ﬁxed brain.
Refractive index homogenisation with OPTIClear. We performed chemical
screening using whole-brain lipid extract liposomes and boiled egg whites as
models for tissue hydrophobic and proteinaceous compartments. This led us to
identify three key chemicals which can suitably adjust refractive indices of indi-
vidual compartments of brain tissues. The cocktail of these chemicals is termed
OPTIClear. It is an aqueous solution consisting of 20% (wt/vol) N-methylgluca-
mine, 32% (wt/vol) iohexol and 20.48% (vol/vol) 2,2’-thiodiethanol (TDE), with a
pH between 7 to 8 adjusted with hydrochloric acid.
Immunostained or non-immunohistochemically stained tissues were incubated
in the OPTIClear solution for 6 h or more at 37 °C, when maximal tissue
transparency is usually achieved. A volume of OPTIClear three times that of the
tissue volume is usually sufﬁcient. Gentle agitation can facilitate penetration of the
reagents into the tissue. The OPTIClear solution used for refractive index
homogenisation should be used as the mounting medium for subsequent
microscopy. The sample can be stored in OPTIClear solution indeﬁnitely at room
temperature. For prolonged storage, the addition of 0.01% sodium azide is
recommended to avoid microbial growth. One can repeat the immunostaining after
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restoring the sample by washing the cleared sample in 1× PBST overnight at room
temperature.
Confocal microscopy and image acquisition. Imaging of stained and refractive
index-homogenised tissue was performed using a Leica SP5 Confocal Microscope
(Leica, Germany) and a Carl Zeiss LSM 780 Confocal Microscope (Carl Zeiss,
Oberkochen, Germany) at the Facility for Imaging by Light Microscopy (FILM)
facility in Hammersmith Hospital, Imperial College London. For images acquired
on the Leica SP5 microscope, a ×10 objective (Plan-Apochromat CS; numerical
aperture, 0.40; working distance, 2.2 mm), ×20 objective (Plan-Apochromat CS;
numerical aperture, 0.70; working distance, 0.59 mm), ×40 objective (Plan-Apoc-
hromat; numerical aperture, 0.85; working distance, 0.21 mm) and ×63 objective
(Plan-Apochromat CS; oil immersion; numerical aperture, 1.40; working distance,
0.14 mm) were used. For images acquired on the Carl Zeiss LSM780 microscope, a
×10 objective (Plan-Apochromat Ph1 M27; numerical aperture, 0.45; working
distance, 2.0 mm), ×20 objective (Plan-Apochromat Ph2 M27; numerical aperture,
0.45; working distance, 0.46 mm), ×40 objective (Oil immersion; DIC M27;
numerical aperture, 1.40; working distance, 0.13 mm) and ×63 objective (Plan-
Apochromat, oil immersion; DIC M27; numerical aperture, 1.40; working distance,
0.19 mm) were used. The laser excitation wavelengths used were 405 nm, 488 nm,
543 nm and 594 nm. For tissue stained with cresyl violet, argon laser excitation at
488 nm was used. Detection spectra range of ~570–700 nm was used to obtain good
contrast with minimal detection of autoﬂuorescence signal.
Data analysis. Image visualisation was performed using Fiji (Image J, NIH), Zen
Black (Carl Zeiss, Germany) and Zen Blue (Carl Zeiss, Germany) software; Max-
imum intensity projections and z-depth colour coding were performed using Fiji
and Zen Black software; 3D renderings were performed using Zen Blue and Imaris
(Bitplane, Belfast, UK) software; Stitching was performed using Fiji, Zen Black and
Adobe After Effects (Adobe, UK). Manual neuron tracing and Sholl analysis was
performed using simple neurite tracer in Fiji, while automated neuron counting
was performed using the “spots” tool in Imaris.
Ethical considerations. The work was conducted under ethical approval held by
the Parkinson’s UK Tissue Bank at Imperial College London (Registered charity in
England and Wales (258197) and in Scotland (SC037554); MREC approval
reference number: 07/MRE09/72). Use of tissue from the Corsellis collection was
under MREC approval (reference number: 14/SC/0098). Informed consent was
obtained prospectively for the use of all post-mortem brain tissues and brain
samples were obtained and prepared in accordance to the Wales Research Ethics
Committee approved protocols.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the paper and the Supplementary Information ﬁle.
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